Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125284283 | 12528428 | 3 | F | 20160822 | 20160705 | 20160829 | EXP | US-JNJFOC-20160625552 | JANSSEN | 0.00 | A | F | Y | 58.06000 | KG | 20160829 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125284283 | 12528428 | 1 | SS | TOPAMAX | TOPIRAMATE | 1 | Oral | 600 MG IN MORNING AND 600 MG IN EVENING, STARTED YEARS AGO AND ALMOST OUT | N | 0 | 600 | MG | UNSPECIFIED | BID | |||||
| 125284283 | 12528428 | 2 | PS | TOPAMAX | TOPIRAMATE | 1 | Oral | 600 MG IN MORNING AND 600 MG IN EVENING, STARTED YEARS AGO AND ALMOST OUT | N | 20505 | 600 | MG | UNSPECIFIED | BID | |||||
| 125284283 | 12528428 | 3 | C | NAPROXEN. | NAPROXEN | 1 | Unknown | COMPLETELY OUT | 0 | 500 | MG | UNSPECIFIED | |||||||
| 125284283 | 12528428 | 4 | C | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Unknown | STARTED YEARS AGO AND ALMOST OUT | 0 | 150 | MG | UNSPECIFIED | |||||||
| 125284283 | 12528428 | 5 | C | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Unknown | STARTED YEARS AGO AND ALMOST OUT | 0 | 150 | MG | UNSPECIFIED | |||||||
| 125284283 | 12528428 | 6 | C | MAGNESIUM | MAGNESIUM | 1 | Unknown | 0 | 1000 | MG | UNSPECIFIED | ||||||||
| 125284283 | 12528428 | 7 | C | ALPHA LIPOIC ACID | .ALPHA.-LIPOIC ACID | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125284283 | 12528428 | 1 | Migraine prophylaxis |
| 125284283 | 12528428 | 2 | Fibromyalgia |
| 125284283 | 12528428 | 3 | Migraine |
| 125284283 | 12528428 | 4 | Migraine |
| 125284283 | 12528428 | 5 | Fibromyalgia |
| 125284283 | 12528428 | 6 | Product used for unknown indication |
| 125284283 | 12528428 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125284283 | 12528428 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125284283 | 12528428 | Feeling abnormal | |
| 125284283 | 12528428 | Incorrect dose administered | |
| 125284283 | 12528428 | Malaise | |
| 125284283 | 12528428 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |